News

The ENHANCE Phase 3b clinical trial is evaluating the safety and efficacy of a modified treatment regimen of Briumvi for ...
Scientists at the University of Edinburgh are using the small minnow fish to study how MS damages the protective coating ...
NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...
Although benzodiazepines like Valium and Xanas are often prescribed to treat mental health issues and inflammation-related diseases, Virginia Commonwealth University (VCU) researchers are ...
April is Parkinson's disease awareness month. About one million Americans have Parkinson's and that figure could jump to 1.2 ...
A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a study published on ...
Ageing is associated with significant immunological changes that can influence both the progression of the disease and the ...
Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...
Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...
As we age, blood stem cells, the essential source of new blood cells in the body, can accumulate genetic mutations. These ...
Every organ in our body contains a small number of adult stem cells that are specific to its niche. These cells act like a ...
The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.